ArticleCureus2026
Norovirus on Cruise Ships: A Recurring Sentinel Event.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Norovirus remains the leading cause of acute gastroenteritis outbreaks worldwide and is particularly well adapted for transmission aboard cruise ships due to its low infectious dose, prolonged environmental persistence, and rapid person-to-person spread. We reviewed recent outbreaks to highlight recurring norovirus outbreaks and gaps in maritime surveillance. These demonstrate the vulnerability of cruise ships to rapid viral amplification and international dissemination. Current surveillance relies predominantly on symptomatic case reporting, limiting the ability to distinguish between single-source introduction, environmental persistence, foodborne transmission, and emergence of novel recombinant strains. Recent modelling studies have shown that early diagnosis and isolation of symptomatic individuals substantially reduce secondary transmission, yet routine genomic surveillance is rarely implemented onboard. Wastewater-based surveillance offers a practical, non-invasive early warning approach that can be integrated into existing ship infrastructure and complemented by genomic sequencing to identify circulating variants and transmission pathways. Incorporating molecular and wastewater surveillance into routine maritime health programmes would strengthen outbreak detection, improve infection control, and enhance global preparedness for recurrent norovirus outbreaks associated with international cruise travel.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.